PharmaLoom Information

PharmaLoom, LLC PharmaLoom is a US based consulting and technology firm specializing in clinical pharmacology, PK/PD modeling, regulatory intelligence, early-phase study design and Japanese bridging for clinical development. We help biotech sponsors, investors, and clinical teams accelerate development by delivering adaptive roadmaps that unify pharmacometric data, regulatory strategy, and operational execution. Our consultants bring decades of experience from big pharma, CROs, and biotech, with proven leadership in CNS, cardio-metabolic, infectious disease, renal, and rare disease programs. We support clients end-to-end—from FIH and proof-of-concept trials, to biomarker strategy, IND/NDA submissions, and investor readiness. PharmaLoom also builds SaaS-enabled solutions that modernize study planning through AI-driven analytics and blockchain-based data integrity. Our “Regulatory Rails” framework ensures every deliverable is aligned with evolving FDA/HHS policy, dual-pathway planning, and sponsor ROI. What we deliver: • Clinical development roadmaps & risk/benefit assessments • PK/PD analyses, simulations & regulatory waivers • Clinical pharmacology trial design (DDI, ADME, bridging, special populations) • Regulatory documents: IBs, INDs, protocols, CSRs, briefing packages • Gap analyses, investor strategy & diligence support PharmaLoom weaves scientific clarity into complex development challenges—helping clients move faster, de-risk investment, and stay ahead of regulatory change.